AdaptHealth Corp. (NASDAQ:AHCO) Stock Holdings Raised by First Eagle Investment Management LLC

First Eagle Investment Management LLC lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 50.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 897,752 shares of the company’s stock after purchasing an additional 302,801 shares during the period. First Eagle Investment Management LLC’s holdings in AdaptHealth were worth $8,978,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of AHCO. GAMMA Investing LLC boosted its holdings in AdaptHealth by 197.1% in the first quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock worth $29,000 after purchasing an additional 1,683 shares during the period. Covestor Ltd lifted its position in shares of AdaptHealth by 279.6% in the 1st quarter. Covestor Ltd now owns 3,109 shares of the company’s stock worth $36,000 after buying an additional 2,290 shares during the last quarter. Blue Trust Inc. acquired a new position in shares of AdaptHealth in the 2nd quarter valued at about $85,000. Innealta Capital LLC bought a new stake in shares of AdaptHealth during the 2nd quarter valued at about $101,000. Finally, Quest Partners LLC raised its stake in AdaptHealth by 11,522.7% during the second quarter. Quest Partners LLC now owns 10,228 shares of the company’s stock worth $102,000 after acquiring an additional 10,140 shares during the period. Institutional investors own 82.67% of the company’s stock.

Insider Buying and Selling

In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of AdaptHealth stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total transaction of $45,040.00. Following the sale, the director now owns 36,899 shares of the company’s stock, valued at approximately $415,482.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 4.43% of the company’s stock.

Analyst Ratings Changes

Separately, Royal Bank of Canada restated an “outperform” rating and issued a $13.00 target price on shares of AdaptHealth in a research note on Monday, August 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, AdaptHealth presently has a consensus rating of “Hold” and a consensus target price of $10.70.

AdaptHealth Stock Performance

Shares of AHCO opened at $11.30 on Friday. The firm has a fifty day moving average of $10.74 and a 200-day moving average of $10.43. The company has a market cap of $1.51 billion, a price-to-earnings ratio of -2.14, a price-to-earnings-growth ratio of 1.75 and a beta of 1.10. The company has a debt-to-equity ratio of 1.38, a quick ratio of 0.94 and a current ratio of 1.15. AdaptHealth Corp. has a 1 year low of $6.37 and a 1 year high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The firm had revenue of $805.98 million for the quarter, compared to analyst estimates of $802.62 million. During the same period in the previous year, the firm earned $0.16 earnings per share. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. As a group, equities analysts anticipate that AdaptHealth Corp. will post 0.87 earnings per share for the current year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.